These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1622160)

  • 41. Comparative antimicrobial activity and post-antibiotic effect of azithromycin, clarithromycin and roxithromycin against some respiratory pathogens.
    Ferrara A; Dos Santos C; Cimbro M; Grassi GG
    Int J Antimicrob Agents; 1996 Aug; 7(3):181-6. PubMed ID: 18611754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
    Zhanel GG; Roberts D; Waltky A; Laing N; Nichol K; Smith H; Noreddin A; Bellyou T; Hoban DJ
    J Antimicrob Chemother; 2002 May; 49(5):807-12. PubMed ID: 12003975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Killing rate and growth rate comparison for newer beta-lactamase-stable oral beta-lactams against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
    Yourassowsky E; Van der Linden MP; Crokaert F
    Chemotherapy; 1992; 38(1):7-13. PubMed ID: 1618006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
    Wallrauch-Schwarz C; Milatovic D; Braveny I
    Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bactericidal activities of methoxyfluoroquinolones gatifloxacin and moxifloxacin against aerobic and anaerobic respiratory pathogens in serum.
    Stein GE; Schooley S; Tyrrell KL; Citron DM; Goldstein EJ
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1308-12. PubMed ID: 12654663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Activity of cefuroxime against bacterial strains isolated from acute otitis media].
    Simonet M; Herrmann JL; Veron M
    Pathol Biol (Paris); 1990 May; 38(5):355-7. PubMed ID: 2367151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cefditoren versus community-acquired respiratory pathogens: time-kill studies.
    Mezzatesta ML; Gona F; Marchese G; Nicolosi D; Toscano MA; Stefani S; Nicoletti G
    J Chemother; 2009 Aug; 21(4):378-82. PubMed ID: 19622454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers.
    Naber KG; Theuretzbacher U; Kinzig M; Savov O; Sörgel F
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1659-65. PubMed ID: 9661000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.
    Jones RN; Biedenbach DJ; Croco MA; Barrett MS
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):573-8. PubMed ID: 9764398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
    Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.
    Van der Auwera P
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1783-90. PubMed ID: 2556079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postantibiotic effect of ceftibuten on respiratory pathogens.
    Chin NX; Huang HB; Neu HC
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S84-7. PubMed ID: 7567315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bactericidal activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae and streptococcal pathogens.
    Gu JW; Scully BE; Neu HC
    J Clin Pharmacol; 1991 Dec; 31(12):1146-50. PubMed ID: 1837032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Resistance surveillance of major pathogens for adult community-acquired respiratory tract infections in China: a multicenter study 2012].
    Zhao C; Zhang F; Wang Z; Cao B; Xu X; Sun H; Zhang R; Hu Y; Liu Z; Du Y; Chen R; Zhuo C; Su D; Liu Y; Hu B; Wang H
    Zhonghua Jie He He Hu Xi Za Zhi; 2015 Jan; 38(1):18-22. PubMed ID: 25791651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers.
    Israel D; Gillum JG; Turik M; Harvey K; Ford J; Dalton H; Towle M; Echols R; Heller AH; Polk R
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2193-9. PubMed ID: 8257144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
    Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.
    Neu HC
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S88-92. PubMed ID: 7567316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Serotype distribution and drug resistance of
    Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
    Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
    [No Abstract]   [Full Text] [Related]  

  • 60. Activity of cefditoren against respiratory pathogens.
    Clark CL; Nagai K; Dewasse BE; Pankuch GA; Ednie LM; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2002 Jul; 50(1):33-41. PubMed ID: 12096004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.